Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» SAGE-547
SAGE-547
FDA reviewers: REMS could allay safety concerns for Sage's brexanolone
BioCentury
Wed, 10/31/18 - 06:47 pm
FDA
SAGE Therapeutics
postpartum depression
SAGE-547
brexanolone
REMS
The FDA just signed off on a Formula 1 pivotal track for Sage’s postpartum depression drug
Endpoints
Tue, 12/6/16 - 09:46 am
FDA
SAGE Therapeutics
postpartum depression
SAGE-547
Sage Therapeutics shares surge 45% on positive trial of postpartum depression drug
Marketwatch
Tue, 07/12/16 - 11:15 am
SAGE Therapeutics
SAGE-547
postpartum depression
Sage Therapeutics, Inc: Overhyped Lead Drug Headed For Failure
Seeking Alpha
Wed, 03/23/16 - 09:43 pm
SAGE Therapeutics
SAGE-547
super-refractory status epilepticus
SRSE
Sage Psychiatric Drug Shows Activity Hint in Small Muscle Tremor Study
TheStreet.com
Thu, 09/3/15 - 06:32 pm
SAGE Therapeutics
SAGE-547
essential tremors
Sage gets a peek at success treating postpartum depression, and its shares soar
Fierce Biotech
Tue, 06/9/15 - 09:38 am
SAGE Therapeutics
postpartum depression
SAGE-547
Biotech upstart Sage sees early efficacy for rare brain seizure drug
Fierce Biotech
Tue, 11/11/14 - 10:48 am
SAGE Therapeutics
SAGE-547
Severe Epileptic Patients in Coma Respond to Sage Therapeutics Experimental Drug
TheStreet.com
Mon, 11/10/14 - 08:11 am
epilepsy
SAGE Therapeutics
SAGE-547